Paloma Partners Management CO Syndax Pharmaceuticals Inc Transaction History

Paloma Partners Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$4.26 - $6.86 $53,250 - $85,750	-12,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.6 - $8.42 $45,000 - $105,250	12,500 New	12,500 $56,000
Q2 2018 Aug 14, 2018	SELL	$6.93 - $14.63 $95,634 - $201,894	-13,800 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$8.71 - $14.82 $22,646 - $38,532	-2,600 Reduced 15.85%	13,800 $196,000
Q4 2017 Feb 14, 2018	BUY	$7.8 - $12.94 $127,920 - $212,216	16,400	16,400 $144,000

227

88.3M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $895M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.